Congenital Corneal Opacity in 22q11.2 Deletion Syndrome: A Case Series

Supplemental Digital Content is Available in the Text. Purpose: The purpose of this study was to describe the deep phenotype of congenital corneal opacities (CCO) in patients with 22q11.2 deletion syndrome (22q11.2 DS) and to identify putative regions or genes that could explain the CCO. Methods: A retrospective chart review was conducted to identify patients with 22q11.2 DS seen in the ophthalmology clinic of a tertiary referral children's hospital. Thirty patients were identified, with molecular confirmation. Twenty-six did not show structural anterior segment anomalies aside from posterior embryotoxon (n = 4), whereas 4 had bilateral CCO, of which 3 had preoperative images. We reviewed medical, operative, and pathology reports; anterior segment optical coherence tomography; high-frequency ultrasound; histopathologic slides; and genetic testing. To identify putative genes responsible for CCO, chromosomal breakpoints in patients with and without CCO were compared. Results: In the 3 patients with preoperative imaging and CCO, a pattern of paracentral corneal opacification with central clearing accompanied by iridocorneal or keratolenticular adhesions was observed. Anterior segment optical coherence tomography and histopathologic images showed central stromal thinning with a residual structure consistent with Descemet membrane. One patient presented at birth with unilateral corneal perforation, suggestive of likely stromal thinning. A comparison of the breakpoints across all cases failed to reveal unique regions or genes in patients with CCO. Conclusions: 22q11.2 DS can rarely be associated with CCO. We describe a consistent pattern of central clearing related to posterior stromal thinning, with or without ICA/KLA. Possible candidate genes for corneal opacification in 22q11.2 DS remain elusive.

[1]  C. Chu,et al.  Ocular Phenotype of Peters-Plus Syndrome , 2021, Cornea.

[2]  Y. M. Coulson-Thomas,et al.  Distribution and Function of Glycosaminoglycans and Proteoglycans in the Development, Homeostasis and Pathology of the Ocular Surface , 2020, Frontiers in Cell and Developmental Biology.

[3]  D. de Freitas,et al.  Primary Pediatric Keratoplasty: Etiology, Graft Survival, And Visual Outcome. , 2019, American journal of ophthalmology.

[4]  K. Sullivan Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome , 2019, Immunological reviews.

[5]  B. Bozkurt,et al.  Ocular Findings in Children With 22q11.2 Deletion Syndrome. , 2016, Journal of pediatric ophthalmology and strabismus.

[6]  F. Malecaze,et al.  Collagens and proteoglycans of the cornea: importance in transparency and visual disorders , 2016, Cell and Tissue Research.

[7]  R. Zori,et al.  A Case of 22q11.2 Deletion Syndrome with Peters Anomaly, Congenital Glaucoma, and Heterozygous Mutation in CYP1B1 , 2015, Ophthalmic genetics.

[8]  E. Utine,et al.  A Case of 22q11.2 Deletion Syndrome with Right Microphthalmia and Left Corneal Staphyloma , 2014, Ophthalmic genetics.

[9]  Y. Yu,et al.  Clinical Outcome of Penetrating Keratoplasty in Patients 5 Years or Younger: Peters Anomaly Versus Sclerocornea , 2013, Cornea.

[10]  K. Nischal A new approach to the classification of neonatal corneal opacities , 2012, Current opinion in ophthalmology.

[11]  J. Sowden,et al.  Chromosome abnormalities and the genetics of congenital corneal opacification , 2011, Molecular vision.

[12]  L. el Matri,et al.  Pediatric penetrating keratoplasty: indications and outcomes. , 2011, Transplantation proceedings.

[13]  K. Sullivan,et al.  Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome) , 2011, Medicine.

[14]  M. Mannis,et al.  Primary Pediatric Keratoplasty: Indications and Outcomes , 2009, Cornea.

[15]  Y. Alanay,et al.  Unilateral Peters' anomaly in an infant with 22q11.2 deletion syndrome. , 2008, Clinical dysmorphology.

[16]  S. Krishnaiah,et al.  Outcome of Penetrating Keratoplasty for Peters Anomaly , 2008, Cornea.

[17]  E. Zackai,et al.  Sclerocornea associated with the chromosome 22q11.2 deletion syndrome , 2008, American journal of medical genetics. Part A.

[18]  R. Shprintzen Velo-cardio-facial syndrome: 30 Years of study. , 2008, Developmental disabilities research reviews.

[19]  K. Devriendt,et al.  Ocular findings in children with a microdeletion in chromosome 22q11.2 , 2008, European Journal of Pediatrics.

[20]  E. Zackai,et al.  Ocular findings in the chromosome 22q11.2 deletion syndrome. , 2007, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[21]  K. Devriendt,et al.  Unilateral Peters' anomaly in a patient with DiGeorge syndrome. , 2005, Journal of pediatric ophthalmology and strabismus.

[22]  C. Connon,et al.  Transparency, swelling and scarring in the corneal stroma , 2003, Eye.

[23]  J. Grigg,et al.  Penetrating keratoplasty in children: visual and graft outcome , 2003, The British journal of ophthalmology.

[24]  Y. Ogura,et al.  Ocular and systemic features of Peters’ anomaly , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[25]  H F Edelhauser,et al.  Ultrastructure in anterior and posterior stroma of perfused human and rabbit corneas. Relation to transparency. , 1995, Investigative ophthalmology & visual science.

[26]  F. Fitzke,et al.  Refractive index of the human corneal epithelium and stroma. , 1995, Journal of refractive surgery.

[27]  P. Scambler,et al.  DiGeorge syndrome: part of CATCH 22. , 1993, Journal of medical genetics.

[28]  D. Albert,et al.  The Usefulness of Routine Alcian Blue Staining of Corneal Specimens , 1988, Cornea.